The study suggests that Optibrium’s augmented chemistry can replace the need for human clinical trials when developing new flavor and fragrance ingredients.
PacBio s Precision Health Partnership, NVIDIA s Open Source SDK, More bio-itworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bio-itworld.com Daily Mail and Mail on Sunday newspapers.
Optibrium Limited, a leading provider of software and artificial intelligence (AI) solutions for drug discovery, has announced the publication of a peer-reviewed study in the Journal of Computer-Aided Molecular Design, “Imputation of Sensory Properties Using Deep Learning”.
The study demonstrates accuracy and predictive capability of proprietary deep learning method for developing flavours and fragrances, and in drug discovery.